{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:26:28Z","timestamp":1791300388213,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00228-012-1357-8","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T08:08:06Z","timestamp":1344499686000},"page":"605-616","source":"Crossref","is-referenced-by-count":12,"title":["Methodology for a multinational case\u2013population study on liver toxicity risks with NSAIDs: the Study of Acute Liver Transplant (SALT)"],"prefix":"10.1007","volume":"69","author":[{"given":"Sinem Ezgi","family":"Gulmez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Larrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Lignot-Maleyran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Perez-Gutthann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"B\u00e9nichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Bissoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Horsmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bernuau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Thorburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(98)80188-8","volume":"29","author":"W Steenbergen Van","year":"1998","unstructured":"Van Steenbergen W, Peeters P, De Bondt J, Staessen D, Buscher H, Laporta T, Roskams T, Desmet V (1998) Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol 29:135\u2013141","journal-title":"J Hepatol"},{"key":"1357_CR2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(05)74867-4","volume":"353","author":"PA McCormick","year":"1999","unstructured":"McCormick PA, Kennedy F, Curry M, Traynor O (1999) COX 2 inhibitor and fulminant hepatic failure. Lancet 353:40\u201341","journal-title":"Lancet"},{"key":"1357_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2796.2000.00612.x","volume":"247","author":"A Schattner","year":"2000","unstructured":"Schattner A, Sokolovskaya N, Cohen J (2000) Fatal hepatitis and renal failure during treatment with nimesulide. J Intern Med 247:153\u2013155","journal-title":"J Intern Med"},{"key":"1357_CR4","first-page":"89","volume":"1","author":"P Weiss","year":"1999","unstructured":"Weiss P, Mouallem M, Bruck R, Hassin D, Tanay A, Brickman CM, Farfel Z, Bar-Meir S (1999) Nimesulide-induced hepatitis and acute liver failure. Isr Med Assoc J 1:89\u201391","journal-title":"Isr Med Assoc J"},{"key":"1357_CR5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0168-8278(00)80208-1","volume":"32","author":"RJ Andrade","year":"2000","unstructured":"Andrade RJ, Lucena MI, Fernandez MC, Gonzalez M (2000) Fatal hepatitis associated with nimesulide. J Hepatol 32:174","journal-title":"J Hepatol"},{"key":"1357_CR6","first-page":"596","volume":"72","author":"MA Macia","year":"2002","unstructured":"Macia MA, Carvajal A, del Pozo JG, Vera E, del Pino A (2002) Hepatotoxicity associated with nimesulide: data from the Spanish Pharmacovigilance System. Clin Pharmacol Ther 72:596\u2013597","journal-title":"Clin Pharmacol Ther"},{"key":"1357_CR7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002280100312","volume":"57","author":"G Merlani","year":"2001","unstructured":"Merlani G, Fox M, Oehen HP, Cathomas G, Renner EL, Fattinger K, Schneemann M, Kullak-Ublick GA (2001) Fatal hepatoxicity secondary to nimesulide. Eur J Clin Pharmacol 57:321\u2013326","journal-title":"Eur J Clin Pharmacol"},{"key":"1357_CR8","unstructured":"(2007) Nimesulide withdrawal too little, too late? Irish Pharmacy J85"},{"key":"1357_CR9","unstructured":"Finish Medicines Agency (2002) The sale of Nimed, an anti-inflammatory analgesic, is temporarily suspended due to its adverse liver effects. Available at: http:\/\/www.fimea.fi\/whats_new\/1\/0\/the_sale_of_nimed_an_anti-inflammatory_analgesic_is_temporarily_suspended_due_to_its_adverse_liver_effects"},{"key":"1357_CR10","unstructured":"Irish Medicines Board (IMB) (2007) IMB announces immediate suspension of the marketing of medicines containing nimesulide. IRB, Dublin"},{"key":"1357_CR11","unstructured":"World Health Organization (WHO) (2007). Oral nimesulide: marketing suspended in Ireland due to reports of liver failure. WHO Information Exchange System Alert No 113 (23 May 2007). WHO, Geneva"},{"key":"1357_CR12","unstructured":"European Medicines Agency (EMEA) (2004) Committee for proprietary medicinal products opinion following an article 31 referral. Nimesulide-containing products. EMEA Press Office, London"},{"key":"1357_CR13","unstructured":"European Medicines Agency (EMEA) (2007) European Medicines Agency recommends restricted use of nimesulide-containing medicinal products. EMEA Press Office, London"},{"key":"1357_CR14","unstructured":"European Medicines Agency (EMEA) (2007) Questions and answers on the CHMP recommendation on nimesulide-containing medicines. EMEA Agency Press Office, London"},{"key":"1357_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1472-8206.2006.00416.x","volume":"20","author":"M Lapeyre-Mestre","year":"2006","unstructured":"Lapeyre-Mestre M, de Castro AM, Bareille MP, Del Pozo JG, Requejo AA, Arias LM, Montastruc JL, Carvajal A (2006) Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems. Fundam Clin Pharmacol 20:391\u2013395","journal-title":"Fundam Clin Pharmacol"},{"key":"1357_CR16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/pds.1966","volume":"19","author":"CH Lee","year":"2010","unstructured":"Lee CH, Wang JD, Chen PC (2010) Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs. Pharmacoepidemiol Drug Saf 19:708\u2013714","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1357_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/bmj.327.7405.18","volume":"327","author":"G Traversa","year":"2003","unstructured":"Traversa G, Bianchi C, Da Cas R, Abraha I, Menniti-Ippolito F, Venegoni M (2003) Cohort study of hepatotoxicity associated with nimesulide and other non-steroidal anti-inflammatory drugs. Br Med J 327:18\u201322","journal-title":"Br Med J"},{"key":"1357_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/11592140-000000000-00000","volume":"34","author":"H Theophile","year":"2011","unstructured":"Theophile H, Laporte JR, Moore N, Martin KL, Begaud B (2011) The case-population study design: an analysis of its application in pharmacovigilance. Drug Saf 34:861\u2013868","journal-title":"Drug Saf"},{"key":"1357_CR19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","volume":"46","author":"C Benichou","year":"1993","unstructured":"Benichou C, Danan G, Flahault A (1993) Causality assessment of adverse reactions to drugs\u2014II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 46:1331\u20131336","journal-title":"J Clin Epidemiol"},{"key":"1357_CR20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C (1993) Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 46:1323\u20131330","journal-title":"J Clin Epidemiol"},{"key":"1357_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","volume":"10","author":"IR Edwards","year":"1994","unstructured":"Edwards IR, Biriell C (1994) Harmonisation in pharmacovigilance. Drug Saf 10:93\u2013102","journal-title":"Drug Saf"},{"key":"1357_CR22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2710.2003.00475.x","volume":"28","author":"AF Macedo","year":"2003","unstructured":"Macedo AF, Marques FB, Ribeiro CF, Teixeira F (2003) Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 28:137\u2013143","journal-title":"J Clin Pharm Ther"},{"key":"1357_CR23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2165\/00002018-199717060-00004","volume":"17","author":"RH Meyboom","year":"1997","unstructured":"Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR (1997) Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 17:374\u2013389","journal-title":"Drug safety: An International Journal of Medical Toxicology and Drug Experience"},{"key":"1357_CR24","volume-title":"Guidelines for ATC classification and DDD assignment 2011","author":"Methodology W.C.C.f.D.S","year":"2010","unstructured":"Methodology W.C.C.f.D.S (2010) Guidelines for ATC classification and DDD assignment 2011. WHO Collaborating Centre for Drug Statistics Methodology, Oslo"},{"key":"1357_CR25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jclinepi.2005.08.012","volume":"59","author":"Y Arimone","year":"2006","unstructured":"Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Molimard M, Moore N, Haramburu F (2006) A new method for assessing drug causation provided agreement with experts\u2019 judgment. J Clin Epidemiol 59:308\u2013314","journal-title":"J Clin Epidemiol"},{"key":"1357_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00228-004-0869-2","volume":"61","author":"Y Arimone","year":"2005","unstructured":"Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, Molimard M, Haramburu F (2005) Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 61:169\u2013173","journal-title":"Eur J Clin Pharmacol"},{"key":"1357_CR27","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2125.2007.02937.x","volume":"64","author":"Y Arimone","year":"2007","unstructured":"Arimone Y, Miremont-Salame G, Haramburu F, Molimard M, Moore N, Fourrier-Reglat A, Begaud B (2007) Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol 64:482\u2013488","journal-title":"Br J Clin Pharmacol"},{"key":"1357_CR28","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2165\/11537780-000000000-00000","volume":"33","author":"H Theophile","year":"2010","unstructured":"Theophile H, Arimone Y, Miremont-Salame G, Moore N, Fourrier-Reglat A, Haramburu F, Begaud B (2010) Comparison of three methods (consensual expert judgement, algorithmic and probabilistic approaches) of causality assessment of adverse drug reactions: an assessment using reports made to a French pharmacovigilance centre. Drug Saf 33:1045\u20131054","journal-title":"Drug Saf"},{"key":"1357_CR29","doi-asserted-by":"crossref","unstructured":"Gulmez SE, Lignot-Maleyran S, Devries CS, Sturkenboom M, Micon S, Hamoud F, Blin P, Moore N (2012) Administrative complexities for a European observational study despite directives harmonising requirements. Pharmacoepidemiol Drug Saf. doi: 10.1002\/pds.3204 . [Epub ahead of print]. Available at: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22337123","DOI":"10.1002\/pds.3204"},{"issue":"Suppl 3","key":"1357_CR30","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1002\/lt.22421","volume":"17","author":"A Sanchez-Fueyo","year":"2011","unstructured":"Sanchez-Fueyo A (2011) Hot-topic debate on tolerance: immunosuppression withdrawal. Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 17[Suppl 3]:S69\u201373","journal-title":"Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society"},{"key":"1357_CR31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.transproceed.2006.11.010","volume":"39","author":"E Tsochatzis","year":"2007","unstructured":"Tsochatzis E, Koskinas J, Manesis EK, Archimandritis AJ (2007) Liver transplantation in Greek patients: epidemiological data, morbidity, and mortality of 71 patients from a single center with 6\u00a0years of mean follow-up. Transplant Proc 39:1505\u20131507","journal-title":"Transplant Proc"},{"key":"1357_CR32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","volume":"11","author":"C Benichou","year":"1990","unstructured":"Benichou C (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11:272\u2013276","journal-title":"J Hepatol"},{"key":"1357_CR33","unstructured":"MIMS Publications (July 2007). IMB suspension of marketing of nimesulide containing medicines. IMB Notice Information: Human Medicines"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1357-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-012-1357-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-012-1357-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:49:00Z","timestamp":1558687740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-012-1357-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1007\/s00228-012-1357-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]}}}